TrialClinical cancer research : an official journal of the American Association for Cancer Research2016

Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity.

Robert J Kreitman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.